These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19145199)

  • 1. Clinicopathologic features of CDK6 translocation-associated B-cell lymphoproliferative disorders.
    Chen D; Law ME; Theis JD; Gamez JD; Caron LB; Vrana JA; Dogan A
    Am J Surg Pathol; 2009 May; 33(5):720-9. PubMed ID: 19145199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities.
    Gailllard B; Cornillet-Lefebvre P; Le QH; Maloum K; Pannetier M; Lecoq-Lafon C; Grange B; Jondreville L; Michaux L; Nadal N; Ittel A; Luquet I; Struski S; Lefebvre C; Gaillard JB; Lafage-Pochitaloff M; Balducci E; Penther D; Barin C; Collonge-Rame MA; Jimenez-Poquet M; Richebourg S; Lemaire P; Defasque S; Radford-Weiss I; Bidet A; Susin SA; Nguyen-Khac F; Chapiro E;
    Br J Haematol; 2021 Apr; 193(1):72-82. PubMed ID: 33314017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of a t(2;7) translocation linking CDK6 to the IGK locus in CD5(-) monoclonal B-cell lymphocytosis.
    Parker E; Macdonald JR; Wang C
    Cancer Genet; 2011 May; 204(5):260-4. PubMed ID: 21665179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translocation t(2;7)(p11;q21) associated with the CDK6/IGK rearrangement is a rare but recurrent abnormality in B-cell lymphoproliferative malignancies.
    Douet-Guilbert N; Tous C; Le Flahec G; Bovo C; Le Bris MJ; Basinko A; Morel F; De Braekeleer M
    Cancer Genet; 2014 Mar; 207(3):83-6. PubMed ID: 24726269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequencing of t(2;7) translocations reveals a consistent breakpoint linking CDK6 to the IGK locus in indolent B-cell neoplasia.
    Parker EP; Siebert R; Oo TH; Schneider D; Hayette S; Wang C
    J Mol Diagn; 2013 Jan; 15(1):101-9. PubMed ID: 23127611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies.
    Sonoki T; Harder L; Horsman DE; Karran L; Taniguchi I; Willis TG; Gesk S; Steinemann D; Zucca E; Schlegelberger B; Solé F; Mungall AJ; Gascoyne RD; Siebert R; Dyer MJ
    Blood; 2001 Nov; 98(9):2837-44. PubMed ID: 11675358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
    Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
    Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role for concurrent abnormalities of the cyclin D1, p16CDKN2 and p15CDKN2B genes in certain B cell non-Hodgkin's lymphomas. Functional studies in a cell line (Granta 519).
    Jadayel DM; Lukas J; Nacheva E; Bartkova J; Stranks G; De Schouwer PJ; Lens D; Bartek J; Dyer MJ; Kruger AR; Catovsky D
    Leukemia; 1997 Jan; 11(1):64-72. PubMed ID: 9001420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations.
    Corcoran MM; Mould SJ; Orchard JA; Ibbotson RE; Chapman RM; Boright AP; Platt C; Tsui LC; Scherer SW; Oscier DG
    Oncogene; 1999 Nov; 18(46):6271-7. PubMed ID: 10597225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of T lymphocytes from elderly humans to enter the cell cycle is associated with low Cdk6 activity and impaired phosphorylation of Rb protein.
    Arbogast A; Boutet S; Phelouzat MA; Plastre O; Quadri R; Proust JJ
    Cell Immunol; 1999 Oct; 197(1):46-54. PubMed ID: 10555995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of the p53, Rb and p27 tumor suppressor pathways in diffuse large B-cell lymphomas.
    Bai M; Tsanou E; Skyrlas A; Sainis I; Agnantis N; Kanavaros P
    Anticancer Res; 2007; 27(4B):2345-52. PubMed ID: 17695524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic acid-mediated growth arrest of EBV-immortalized B lymphocytes is associated with multiple changes in G1 regulatory proteins: p27Kip1 up-regulation is a relevant early event.
    Zancai P; Cariati R; Rizzo S; Boiocchi M; Dolcetti R
    Oncogene; 1998 Oct; 17(14):1827-36. PubMed ID: 9778049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK; Medina D
    Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
    Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
    Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes.
    Solvason N; Wu WW; Kabra N; Wu X; Lees E; Howard MC
    J Exp Med; 1996 Aug; 184(2):407-17. PubMed ID: 8760794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulated expression of HDAC9 in B cells promotes development of lymphoproliferative disease and lymphoma in mice.
    Gil VS; Bhagat G; Howell L; Zhang J; Kim CH; Stengel S; Vega F; Zelent A; Petrie K
    Dis Model Mech; 2016 Dec; 9(12):1483-1495. PubMed ID: 27799148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD5- B-cell lymphoproliferative disorders presenting in blood and bone marrow. A clinicopathologic study of 40 patients.
    Shapiro JL; Miller ML; Pohlman B; Mascha E; Fishleder AJ
    Am J Clin Pathol; 1999 Apr; 111(4):477-87. PubMed ID: 10191767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD5- small B-cell leukemias are rarely classifiable as chronic lymphocytic leukemia.
    Huang JC; Finn WG; Goolsby CL; Variakojis D; Peterson LC
    Am J Clin Pathol; 1999 Jan; 111(1):123-30. PubMed ID: 9894463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of p18INK4 and p27kip1 cyclin-dependent kinase inhibitors is regulated differently during human B cell differentiation.
    Schrantz N; Beney GE; Auffredou MT; Bourgeade MF; Leca G; Vazquez A
    J Immunol; 2000 Oct; 165(8):4346-52. PubMed ID: 11035070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmablastic transformation of low-grade CD5+ B-cell lymphoproliferative disorder with MYC gene rearrangements.
    Pan Z; Xie Q; Repertinger S; Richendollar BG; Chan WC; Huang Q
    Hum Pathol; 2013 Oct; 44(10):2139-48. PubMed ID: 23791008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.